Quantcast

Latest autoimmune diseases Stories

2014-06-12 08:29:46

-- Parion has a plan for the first clinical trial in patients with dry eye disease to initiate in July 2014 DURHAM, N.C., June 12, 2014 /PRNewswire/ -- Parion Sciences, Inc. (Parion) announced today that Parion and Santen Pharmaceutical Co., Ltd. (Santen) have entered into the "OPTION, LICENSE AND DEVELOPMENT AGREEMENT", an exclusive option agreement for the development and commercialization of P-321 for dry eye disease in certain Asian territories. On May 1, 2014 Parion announced...

2014-06-12 08:29:14

RALEIGH, N.C., June 12, 2014 /PRNewswire/ -- Islet Sciences, Inc. (OTCQB: ISLT), a biopharmaceutical company developing novel technologies for the treatment and diagnosis of metabolic disease, announced today it will present three peer-reviewed posters relating to its differentiated sodium glucose transporter 2 (SGLT2) inhibitor, remogliflozin etabonate, at the 74(th) American Diabetes Association (ADA) Scientific Sessions at the Moscone Center in San Francisco, June 13-17. Two of...

2014-06-11 12:25:52

Raises Thousands to Fund Research and Support for Lupus Community NEW YORK, June 11, 2014 /PRNewswire/ -- The Young Leaders of the S.L.E. Lupus Foundation celebrated the 10(th) anniversary of their highly successful "Night for the Fight" fundraiser. Diagnosed with lupus this past year, Bravo TV's reality TV star Ashlee White was among over 200 guests. HBO Def poet/singer/lupus activist Shanelle Gabrielle served as Master of Ceremonies for the evening. The event featured music by DJ...

2014-06-11 08:30:04

Seattle Children's Research Institute and Kineta Launch the Alliance for Children's Therapeutics SEATTLE, June 11, 2014 /PRNewswire/ -- Seattle Children's Research Institute and biotechnology company Kineta, Inc. today launched the Alliance for Children's Therapeutics (ACT), a first-of-its-kind pediatric research and funding collaboration designed to speed development of new medications for children and teens with lupus nephritis and other autoimmune diseases like multiple sclerosis, Type 1...

2014-06-11 04:21:56

- Findings Show Positive Association Between Adherence and Anti-TNF Therapy Compared to Conventional Therapy PARIS, June 11, 2014 /PRNewswire/ -- AbbVie (NYSE:ABBV) today announced results from its multi-country ALIGN study, which shows that across six chronic immune-mediated inflammatory diseases (IMIDs), adherence to treatment was generally higher in patients being treated with TNF inhibitors compared to patients treated with conventional therapy. Furthermore, patients who were...

2014-06-10 23:13:21

Andrew Louis Botieri has written a new foreword to his poignant autobiographical book “A Celebration of Life: A Story of Hope, a Miracle, and the Power of Attitude”. Boston, MA (PRWEB) June 10, 2014 Andrew Louis Botieri, Scleroderma Survivor & Inspirational Speaker, Writes New Foreword to “A Celebration of Life” to Mark National Scleroderma Awareness Month To mark National Scleroderma Awareness Month in June, Andrew Louis Botieri has written a new foreword to his poignant...

2014-06-10 12:32:19

NEW YORK, June 10, 2014 /PRNewswire/ -- The Lupus Research Institute (LRI) launched the LRI Industry Council, a collaborative initiative founded with 13 leading pharmaceutical and biotechnology companies involved in lupus drug development. The LRI formed the new group to facilitate active collaboration among companies, research leaders, and patient advocates to overcome common obstacles in developing new treatments for lupus. The need for safer and more effective treatments is...

2014-06-09 12:30:42

CHICAGO, June 9, 2014 /PRNewswire-USNewswire/ -- Bruce Richardson, M.D., Ph.D., of The University of Michigan, has been selected as the second recipient of the Lupus Insight Prize. The award provides $200,000 for use in innovative research on lupus, an unpredictable and sometimes fatal autoimmune disease that affects an estimated 1.5 million Americans. The Prize is a collaborative initiative among the Alliance for Lupus Research (ALR), the Lupus Foundation of America (LFA), and the...

2014-06-09 08:30:13

ALBUQUERQUE, N.M., June 9, 2014 /PRNewswire/ -- Exagen Diagnostics, Inc., a leading medical diagnostic company focused in rheumatology, today announced the addition of the Avise SLE Prognostic panel to its testing services. http://photos.prnewswire.com/prnvar/20131028/LA05125LOGO Designed to supplement the Avise SLE+ Connective Tissue diagnostic, Avise SLE Prognostic is a comprehensive prognostic panel that helps physicians assess potential risk for lupus nephritis, neuropsychiatric...

2014-06-09 08:28:15

- Glaucoma Phase II ongoing study will enroll patients to the next higher dose without an interim analysis, no safety issues have been recorded PETACH TIKVA, Israel, June 9, 2014 /PRNewswire/ -- Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that its subsidiary, OphthaliX, Inc., has issued an update on its clinical developments and strategic...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related